Pharmaceutically active sulfonyl hydrazide derivatives

1 2 1 2 123 161 12 3 16 The present invention is related to sulfonyl hydrazide derivatives for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such sulfonyl hydrazide derivatives. Said sulfonyl hydrazide derivatives are efficient modulators of the JNK p...

Full description

Saved in:
Bibliographic Details
Main Authors Arkinstall, Stephen, Halazy, Serge, Church, Dennis, Camps, Montserrat, Rueckle, Thomas, Gotteland, Jean-Pierre, Biamonte, Marco
Format Patent
LanguageEnglish
Published 07.10.2008
Online AccessGet full text

Cover

Loading…
Abstract 1 2 1 2 123 161 12 3 16 The present invention is related to sulfonyl hydrazide derivatives for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such sulfonyl hydrazide derivatives. Said sulfonyl hydrazide derivatives are efficient modulators of the JNK pathway, they are in particular efficient inhibitors of JNK 2 and 3. The present invention is furthermore related to novel sulfonyl hydrazide derivatives as well as to methods of their preparation. In Formula (I) Arand Arare independently from each other an unsubstituted or substituted aryl or beteroaryl group, Xand Xare independently from each other O or S; R, R, Rare independently from each other hydrogen or a C-C-alkyl substituent or Rforms a substituted or unsubstituted 5-6-membered saturated or unsaturated ring with Ar; or Rand Rform a substituted or unsubstituted 5-6-membered saturated or unsaturated ring; n is an integer from 0 to 5; G is selected from a group comprising or consisting of an unsubstituted or substituted 4-8 membered heterocycle containing at least one heteroatom, or G is a substituted or unstibstituted C-C-alkyl group.
AbstractList 1 2 1 2 123 161 12 3 16 The present invention is related to sulfonyl hydrazide derivatives for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such sulfonyl hydrazide derivatives. Said sulfonyl hydrazide derivatives are efficient modulators of the JNK pathway, they are in particular efficient inhibitors of JNK 2 and 3. The present invention is furthermore related to novel sulfonyl hydrazide derivatives as well as to methods of their preparation. In Formula (I) Arand Arare independently from each other an unsubstituted or substituted aryl or beteroaryl group, Xand Xare independently from each other O or S; R, R, Rare independently from each other hydrogen or a C-C-alkyl substituent or Rforms a substituted or unsubstituted 5-6-membered saturated or unsaturated ring with Ar; or Rand Rform a substituted or unsubstituted 5-6-membered saturated or unsaturated ring; n is an integer from 0 to 5; G is selected from a group comprising or consisting of an unsubstituted or substituted 4-8 membered heterocycle containing at least one heteroatom, or G is a substituted or unstibstituted C-C-alkyl group.
Author Arkinstall, Stephen
Rueckle, Thomas
Camps, Montserrat
Biamonte, Marco
Gotteland, Jean-Pierre
Church, Dennis
Halazy, Serge
Author_xml – sequence: 1
  givenname: Stephen
  surname: Arkinstall
  fullname: Arkinstall, Stephen
– sequence: 2
  givenname: Serge
  surname: Halazy
  fullname: Halazy, Serge
– sequence: 3
  givenname: Dennis
  surname: Church
  fullname: Church, Dennis
– sequence: 4
  givenname: Montserrat
  surname: Camps
  fullname: Camps, Montserrat
– sequence: 5
  givenname: Thomas
  surname: Rueckle
  fullname: Rueckle, Thomas
– sequence: 6
  givenname: Jean-Pierre
  surname: Gotteland
  fullname: Gotteland, Jean-Pierre
– sequence: 7
  givenname: Marco
  surname: Biamonte
  fullname: Biamonte, Marco
BookMark eNrjYmDJy89L5WQwC8hILMpNTE4tLclMTszJqVRITC7JLEtVKC7NScvPq8xRyKhMKUqsykxJVUhJLcosSwTJFvMwsKYl5hSn8kJpbgYFN9cQZw_d0uKCxJLUvJLi-PSiRBBlYG5ibGRkYWZMhBIA2-QxMw
ContentType Patent
CorporateAuthor Laboratories Serono SA
CorporateAuthor_xml – name: Laboratories Serono SA
DBID EFH
DatabaseName USPTO Issued Patents
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EFH
  name: USPTO Issued Patents
  url: http://www.uspto.gov/patft/index.html
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
ExternalDocumentID 07432286
GroupedDBID EFH
ID FETCH-uspatents_grants_074322863
IEDL.DBID EFH
IngestDate Sun Mar 05 22:32:50 EST 2023
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-uspatents_grants_074322863
OpenAccessLink https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7432286
ParticipantIDs uspatents_grants_07432286
PatentNumber 7432286
PublicationCentury 2000
PublicationDate 20081007
PublicationDateYYYYMMDD 2008-10-07
PublicationDate_xml – month: 10
  year: 2008
  text: 20081007
  day: 07
PublicationDecade 2000
PublicationYear 2008
References Derek D. Yang et al.: "Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene" Nature, 389 (6653), pp. 865-870, 1997.
Yoshihiro Kumage et al.: "Human c-Jun N-terminal kinase expression and activation in the nervous system" Brain Res. Mol. Brain Res., 67 (1), pp. 10-17, 1999.
Kanaga Sabapathy et al.: "JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development" Current Biology, 3, pp. 116-125, 1999.
R. Raja Reddy et al.: "New hypoglycemic agents-Part XVI: synthesis and evaluation of N3-aryl-N1-′4-′(3, 4-dihydro-3-oxo-2H-1, 4-benzoxazin-2-yl) acetic acid hydrazidosulfonyllphenyll ureas/thioureas" Indian Journal of Heterocyclic Chemistry, vol. 7, No. 3, pp. 185-188.
(98 49188) 19981100
Xie Xiaoling et al.: "Crystal structure of JNK3: a kinase implicated in neuronal apoptosis" Structure, 6 (8), pp. 983-991, 1998.
(0 330 065) 19890800
Derek D. Yang et al.: "Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2" Immunity, 9, pp. 575-585, 1998.
(WO 01/23378) 20010400
References_xml – year: 19981100
  ident: 98 49188
– year: 19890800
  ident: 0 330 065
– year: 20010400
  ident: WO 01/23378
Score 2.7215059
Snippet 1 2 1 2 123 161 12 3 16 The present invention is related to sulfonyl hydrazide derivatives for use as pharmaceutically active compounds, as well as to...
SourceID uspatents
SourceType Open Access Repository
Title Pharmaceutically active sulfonyl hydrazide derivatives
URI https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7432286
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfVxLSwMxEB7aIqgnRcX6Igev0exu9tGzdFkEZQ8KvZXZPKywbkt311J_vZOtll70msBkSCbzZcI3H8CtFkGAIpEclUk41V8-LyKluVcoaZSwozBwvcNPz1H2Kh8n4aQH2bYX5oOuEV-QL_VdWy-aeUeupPS-OXi-EX92GoGVUx9YVeUcda7tPSGh7ydRH_qJcNSucZodwj6ZoCdb1dQ7oJEewV7ejR5Dz1QnEOWz3e_jcs2wyzWsbkvr-OFsttZL_HrXhmmKi89Okrs-BZaOXx4yvl1k-rZ05JWp-HEmOIMBFfHmHFisCBYQPaFtIWVoMVFejAZH0lKGCXEIwz_NXPwzdwkH_q9Ca3wFg2bZmmuCyaa46fbgGzehdY0
link.rule.ids 230,309,786,808,891,64394
linkProvider USPTO
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfVzJTsMwEB2VglhOIEC0bD5wNWRxlp6hUdiqHEDqLXK8UKSQVlmoytczTqHqBa62NB7Z43ke680DuJKW63IrZJQLFVKsvxya-UJSOxNMCUsPPNf0Dj-P_PiVPYy9cQfiVS_MB14jOkNfquummtXTllyJ6X158HQp_mw0AgujPjAv8imXidQ3iISOE_obsGkw1qjoD6N4D3bQCD7airpag41oH7aSdvQAOqo4BD-ZrH8g5wvC22xDqibXhiFOJgtZ8q93qYjEyPhsRbmrIyDR8OU2pqtF0rfS0FdS68cd9xi6WMarEyCBQGDg3LakzhjzNA-FHXDFB0xjjvF4D3p_mun_M3cJ28ldlD7djx5PYdf5lWsNzqBbl406R8yss4t2O74BIyd4hw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Pharmaceutically+active+sulfonyl+hydrazide+derivatives&rft.inventor=Arkinstall%2C+Stephen&rft.inventor=Halazy%2C+Serge&rft.inventor=Church%2C+Dennis&rft.inventor=Camps%2C+Montserrat&rft.inventor=Rueckle%2C+Thomas&rft.inventor=Gotteland%2C+Jean-Pierre&rft.inventor=Biamonte%2C+Marco&rft.number=7432286&rft.date=2008-10-07&rft.externalDBID=n%2Fa&rft.externalDocID=07432286